KVR PHARMACEUTICALS INC.
$41,000.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2025-2026
Canada
The project aims to develop a novel and improved, multi-dose formulation of desmopressin acetate injection.